Patents by Inventor Werner E. G. Muller

Werner E. G. Muller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of flupirtine the prophylaxis and therapy of diseases associated with an impairment of the hematopoetic cell system
    Patent number: 6034112
    Abstract: The invention relates to the use of flupirtine or its salts as drugs in the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system, for example lymphocytes.Especially important in this respect is the treatment of HIV infected patients/AIDS patients.
    Type: Grant
    Filed: April 16, 1998
    Date of Patent: March 7, 2000
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Gabriela Pergande, Werner E. G. Muller
  • Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system
    Patent number: 6034111
    Abstract: The invention relates to the use of flupirtine or its salts as drugs in the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system, for example lymphocytes. Especially important in this respect is the treatment of HIV infected patients/AIDS patients.
    Type: Grant
    Filed: November 7, 1996
    Date of Patent: March 7, 2000
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Gabriela Pergande, Werner E. G. Muller
  • Avarone and its pharmaceutical compositions and use as an antiviral agent
    Patent number: 5180748
    Abstract: The antitumor and antiviral compound avarone, a process for its production, pharmaceutical compositions containing said compound, and a method of combating susceptible viruses and tumors therewith, are disclosed.
    Type: Grant
    Filed: December 29, 1989
    Date of Patent: January 19, 1993
    Assignee: Merz+Co. GmbH & Co.
    Inventors: Werner E. G. Muller, Rudolf K. Zahn, Eckart Eich
  • Avarol and its production and use as an antitumor agent (I)
    Patent number: 5082865
    Abstract: The antitumor compound avarol, a process for its production, pharmaceutical compositions containing said compound, and a method of combating tumors therewith, are disclosed.
    Type: Grant
    Filed: December 29, 1989
    Date of Patent: January 21, 1992
    Inventors: Werner E. G. Muller, Rudolf K. Zahn, Eckart Eich
  • Use of avarone for the control of AIDS and ARC
    Patent number: 5026732
    Abstract: The invention concerns the use of avarone and pharmaceutical compositions thereof for the control of AIDS and AIDS-Related Complex (ARC).
    Type: Grant
    Filed: December 29, 1989
    Date of Patent: June 25, 1991
    Assignee: Merz & Co. GmbH & Co.
    Inventor: Werner E. G. Muller
  • Use of avarone for the control of adult T-cell leukemia/lymphoma
    Patent number: 5001162
    Abstract: The invention concerns the use of avarone and pharmaceutical compositions thereof for the control of adult T-cell leukemia/lymphoma.
    Type: Grant
    Filed: December 29, 1989
    Date of Patent: March 19, 1991
    Assignee: Merz + Co. GmbH & Co.
    Inventor: Werner E. G. Muller
  • Avarol, process for its production, pharmaceutical compositions thereof, and antiviral use of the same
    Patent number: 4946869
    Abstract: The antiviral compond avarol, a process for its production, pharmaceutical compositions containing said compound, and a method of combating viruses therewith, are disclosed.
    Type: Grant
    Filed: January 17, 1986
    Date of Patent: August 7, 1990
    Assignee: Merz and Co. GmbH & Co.
    Inventors: Werner E. G. Muller, Rudolf K. Zahn, Eckart Eich
  • Use of avarol for the control of AIDS and ARC
    Patent number: 4939177
    Abstract: The invention concerns the use of avarol and its derivatives and pharmaceutical compositions thereof for the control of AIDS and AIDS-related Complex (ARC).
    Type: Grant
    Filed: June 4, 1987
    Date of Patent: July 3, 1990
    Assignee: Merz + Co. GmbH & Co.
    Inventor: Werner E. G. Muller
  • Use of avarol for the control of adult T-cell leukemia/lymphoma
    Patent number: 4939178
    Abstract: The invention concerns the use of avarol and its derivatives and pharmaceutical compositions thereof for the control of adult T-cell leukemia/lymphoma.
    Type: Grant
    Filed: June 4, 1987
    Date of Patent: July 3, 1990
    Assignee: Merz + Co. GmbH & Co.
    Inventor: Werner E. G. Muller